Genetic polymorphisms in the long noncoding RNA MIR2052HG offer a pharmacogenomic basis for the response of breast cancer patients to aromatase inhibitor therapy
- James N. Ingle
- , Fang Xie
- , Matthew J. Ellis
- , Paul E. Goss
- , Lois E. Shepherd
- , Judith Anne W. Chapman
- , Bingshu E. Chen
- , Michiaki Kubo
- , Yoichi Furukawa
- , Yukihide Momozawa
- , Vered Stearns
- , Kathleen I. Pritchard
- , Poulami Barman
- , Erin E. Carlson
- , Matthew P. Goetz
- , Richard M. Weinshilboum
- , Krishna R. Kalari
- , Liewei Wang
Research output: Contribution to journal › Article › peer-review
49
Link opens in a new tab
Citations
(Scopus)